361 results found.
                    
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
NuVasive Launches Modulus TLIF-O Porous Titanium Spine Implant
NuVasive commenced launch of Modulus® TLIF-O, a porous titanium implant for transforaminal lumbar interbod...
Robotics Recap: Orthopedic Executives Remain Bullish
By Mike Evers   Despite normal seasonal softness in capital sales, the first quarter of 2019 was an active one for robotic and digital surgery developments. New entrants into the orthopedic robot market like Zimmer Biomet’s ROSA Knee may lead to longer buying cycles as ...
Global Orthopedic Market Revenue to Exceed $61 Billion in 2023
The global orthopedic market will exceed US $61 billion in revenue in 2023.
NuVasive Reports 1Q19 Revenue of $274.8MM, +5.5% vs. 1Q18
NuVasive posts 1Q19 revenue of USD $274.8MM, +5.5% vs.1Q18.
NuVasive Cohere Porous PEEK Comparative Study Results
NuVasive's Cohere® Porous PEEK interbody demonstrated clear benefits in promoting improved early outcomes in ACDF procedures
Orthopedic Industry Revenue Reaches $51 Billion in 2018
By Mike Evers Download Your Copies
NuVasive Debuts X360 System for Lateral Single-Position Spine Procedures
NuVasive is introducing the X360™ system integrated with Pulse™ automation for
NuVasive Proprietary Porous PEEK Used In First XLIF Cases
NuVasive announced initial XLIF® spinal procedures using the Cohere® XLIF lateral P...
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
4 Orthopedic Robotic and Surgical Tracking Companies to Watch
By Carolyn LaWell The proliferation of computer-assisted technology companies entering the joint replacement, spine and trauma markets indicates to us that industry believes that there's room for product introduction and adoption in robotic- and navigation-based surgery. Much ...
NuVasive Reports 4Q18 Revenue of $288.3MM, +6.3% vs. 4Q17
NuVasive posts 4Q18 revenue of USD $288.3MM, +6.3%vs. 4Q17, with 2018 full-year revenue of
NuVasive Receives Regulatory Clearances for Bone Transport System
NuVasive received FDA 510(k) clearance and CE Mark approval to market Precice® Bone Tra...
AxioMed and NanoFUSE Biologics to be Available for Acquisition
KICVentures seeks funding to prepare its portfolio companies, AxioMed and NanoFUSE Biologics, to be acquis...
Alphatec Announces Stay of Proceedings In NuVasive Patent Lawsuit
Alphatec announced favorable developments in its ongoing patent litigation with NuVasive regarding CoRoent® late...
Smith & Nephew Reports 4Q18 Orthopedic Revenue of $911.8MM, +1.4% vs. 4Q17
Smith & Nephew reports 4Q18 orthopedic revenue of USD $911.8MM, +1.4% vs. 4Q1...
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical Report Preliminary 4Q18 and FY 2018 Results
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical reported preliminary 4Q18 and FY 2018 results.
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
NuVasive Gains FDA Clearance for Monolith Corpectomy
NuVasive received FDA 510(k) clearance to market an expanded indication for the Monolith® corpectomy system...
NuVasive Launches Brigade for ALIF Surgery
NuVasive announced U.S. commercial launch of the Brigade® Lateral device for lateral anterior lumbar interbody fusio...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
Alphatec Spine Reports 3Q18 Revenue of $23MM, -0.4% vs. 3Q17
Alphatec Spine reports 3Q18 revenue of US $23MM, -0.4% vs. 3Q17.
NuVasive Gains FDA Clearance for COHERE in XLIF
NuVasive received FDA 510(k) clearance for the COHERE® Porous PEEK™ device in eXtreme Lateral Interbody Fusion
Smith & Nephew Reports 3Q18 Orthopaedic Revenue of $808.7MM, +2.0% vs. 3Q17
Smith & Nephew reports 3Q18 orthopaedic revenue of US $808.7MM, +2.0% vs. 3Q17
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group